The Federal Trade Commission (FTC) announced on Thursday that it launched the first law enforcement crackdown on “deceptive” claims being made about CBD products. The new action involves complaints against six companies. As part of “Operation CBDeceit,” FTC is mandating that the firms and personnel associated with them stop making a “wide range of scientifically unsupported claims” about their products’ ability to treat medical conditions. Some of the companies will also have to pay monetary judgments.

Marijuana Moment, 12/17/2020 

Open article: